Head-to-Head Comparison of 68Ga-PSMA-11 PET/CT and mpMRI with a Histopathology Gold Standard in the Detection, Intraprostatic Localization, and Determination of Local Extension of Primary Prostate Cancer: Results from a Prospective Single-Center Imaging Trial

Ida Sonni; Ely R. Felker; Andrew T. Lenis; Anthony E. Sisk; Shadfar Bahri; Martin Allen-Auerbach; Wesley R. Armstrong; Voraparee Suvannarerg; Teeravut Tubtawee; Tristan Grogan; David Elashoff; Matthias Eiber; Steven S. Raman; Johannes Czernin; Robert E. Reiter; Jeremie Calais

doi:10.2967/jnumed.121.262398

Research ArticleFeatured Article of the Month

Head-to-Head Comparison of ⁶⁸Ga-PSMA-11 PET/CT and mpMRI with a Histopathology Gold Standard in the Detection, Intraprostatic Localization, and Determination of Local Extension of Primary Prostate Cancer: Results from a Prospective Single-Center Imaging Trial

Ida Sonni, Ely R. Felker, Andrew T. Lenis, Anthony E. Sisk, Shadfar Bahri, Martin Allen-Auerbach, Wesley R. Armstrong, Voraparee Suvannarerg, Teeravut Tubtawee, Tristan Grogan, David Elashoff, Matthias Eiber, Steven S. Raman, Johannes Czernin, Robert E. Reiter and Jeremie Calais

Journal of Nuclear Medicine June 2022, 63 (6) 847-854; DOI: https://doi.org/10.2967/jnumed.121.262398

Ida Sonni

1Ahmanson Translational Theranostics Division, Department of Molecular and Medical Pharmacology, David Geffen School of Medicine, UCLA, Los Angeles, California;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Ely R. Felker

2Department of Radiology, David Geffen School of Medicine, UCLA, Los Angeles, California;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Andrew T. Lenis

3Department of Urology, UCLA, Los Angeles, California;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Anthony E. Sisk

4Department of Pathology, David Geffen School of Medicine, UCLA, Los Angeles, California;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Shadfar Bahri

1Ahmanson Translational Theranostics Division, Department of Molecular and Medical Pharmacology, David Geffen School of Medicine, UCLA, Los Angeles, California;

5Institute of Urologic Oncology, David Geffen School of Medicine, UCLA, Los Angeles, California;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Martin Allen-Auerbach

1Ahmanson Translational Theranostics Division, Department of Molecular and Medical Pharmacology, David Geffen School of Medicine, UCLA, Los Angeles, California;

5Institute of Urologic Oncology, David Geffen School of Medicine, UCLA, Los Angeles, California;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Wesley R. Armstrong

1Ahmanson Translational Theranostics Division, Department of Molecular and Medical Pharmacology, David Geffen School of Medicine, UCLA, Los Angeles, California;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Voraparee Suvannarerg

2Department of Radiology, David Geffen School of Medicine, UCLA, Los Angeles, California;

6Department of Radiology, Faculty of Medicine, Siriraj Hospital, Mahidol University, Bangkok, Thailand;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Teeravut Tubtawee

2Department of Radiology, David Geffen School of Medicine, UCLA, Los Angeles, California;

7Department of Radiology, Prince of Songkla University, Hat Yai, Thailand;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Tristan Grogan

8Department of Medicine Statistics Core, UCLA, Los Angeles, California;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

David Elashoff

8Department of Medicine Statistics Core, UCLA, Los Angeles, California;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Matthias Eiber

1Ahmanson Translational Theranostics Division, Department of Molecular and Medical Pharmacology, David Geffen School of Medicine, UCLA, Los Angeles, California;

9Department of Nuclear Medicine, Klinikum Rechts der Isar, Technical University of Munich, Munich, Germany; and

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Steven S. Raman

2Department of Radiology, David Geffen School of Medicine, UCLA, Los Angeles, California;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Johannes Czernin

1Ahmanson Translational Theranostics Division, Department of Molecular and Medical Pharmacology, David Geffen School of Medicine, UCLA, Los Angeles, California;

5Institute of Urologic Oncology, David Geffen School of Medicine, UCLA, Los Angeles, California;

10Jonsson Comprehensive Cancer Center, UCLA, Los Angeles, California

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Robert E. Reiter

3Department of Urology, UCLA, Los Angeles, California;

5Institute of Urologic Oncology, David Geffen School of Medicine, UCLA, Los Angeles, California;

10Jonsson Comprehensive Cancer Center, UCLA, Los Angeles, California

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Jeremie Calais

1Ahmanson Translational Theranostics Division, Department of Molecular and Medical Pharmacology, David Geffen School of Medicine, UCLA, Los Angeles, California;

5Institute of Urologic Oncology, David Geffen School of Medicine, UCLA, Los Angeles, California;

10Jonsson Comprehensive Cancer Center, UCLA, Los Angeles, California

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Article
Figures & Data
Supplemental
Info & Metrics
PDF

Data supplements

Supplemental Data

Files in this Data Supplement:

Supplemental Data

PreviousNext

In this issue

Journal of Nuclear Medicine

Vol. 63, Issue 6

June 1, 2022

Table of Contents
Table of Contents (PDF)
About the Cover
Index by author
Complete Issue (PDF)

Download PDF

Article Alerts

User Name *

Password *

Email *

Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Your Email *

Your Name *

Send To *

Enter multiple addresses on separate lines or separate them with commas.

You are going to email the following Head-to-Head Comparison of 68Ga-PSMA-11 PET/CT and mpMRI with a Histopathology Gold Standard in the Detection, Intraprostatic Localization, and Determination of Local Extension of Primary Prostate Cancer: Results from a Prospective Single-Center Imaging …

Message Subject (Your Name) has sent you a message from Journal of Nuclear Medicine

Message Body (Your Name) thought you would like to see the Journal of Nuclear Medicine web site.

Your Personal Message

Citation Tools

Head-to-Head Comparison of ⁶⁸Ga-PSMA-11 PET/CT and mpMRI with a Histopathology Gold Standard in the Detection, Intraprostatic Localization, and Determination of Local Extension of Primary Prostate Cancer: Results from a Prospective Single-Center Imaging Trial